Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-32.61%
0%
-32.61%
1 Year
-85.83%
0%
-85.83%
2 Years
-87.84%
0%
-87.84%
3 Years
-84.88%
0%
-84.88%
4 Years
-72.93%
0%
-72.93%
5 Years
-75.69%
0%
-75.69%
Cian Healthcare for the last several years.
Risk Adjusted Returns v/s Sensex 
Returns Beta
Beta has not been calculated since enough price history is not available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.20%
EBIT Growth (5y)
-6.39%
EBIT to Interest (avg)
0.91
Debt to EBITDA (avg)
10.51
Net Debt to Equity (avg)
1.19
Sales to Capital Employed (avg)
0.92
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
34.48%
Institutional Holding
0
ROCE (avg)
13.01%
ROE (avg)
1.16%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
33
Price to Book Value
0.12
EV to EBIT
13.04
EV to EBITDA
6.52
EV to Capital Employed
0.47
EV to Sales
0.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.60%
ROE (Latest)
0.63%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Sep 2024
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
34.4814
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Pankaj Shriniwas Zanwar (13.76%)
Highest Public shareholder
Prakashchandra Rathi (15.42%)
Individual Investors Holdings
59.23%
Half Yearly Results Snapshot (Consolidated) - Sep'24
Sep'24
Mar'24
Change(%)
Net Sales
18.90
61.70
-69.37%
Operating Profit (PBDIT) excl Other Income
-1.42
10.87
-113.06%
Interest
2.41
5.79
-58.38%
Exceptional Items
-12.05
0.00
Consolidate Net Profit
-18.25
0.25
-7,400.00%
Operating Profit Margin (Excl OI)
-7.51%
17.62%
-25.13%
Values in Rs Cr.
Net Sales
Growth in half year ended Sep 2024 is -69.37% vs 89.21% in Mar 2024
Consolidated Net Profit
Growth in half year ended Sep 2024 is -7,400.00% vs 116.89% in Mar 2024
Annual Results Snapshot (Consolidated) - Mar'24
Mar'24
Mar'23
Change(%)
Net Sales
61.70
68.59
-10.05%
Operating Profit (PBDIT) excl Other Income
10.87
12.38
-12.20%
Interest
5.79
5.69
1.76%
Exceptional Items
0.00
0.11
-100.00%
Consolidate Net Profit
0.25
2.03
-87.68%
Operating Profit Margin (Excl OI)
17.62%
18.05%
-0.43%
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2024 is -10.05% vs -11.92% in Mar 2023
Consolidated Net Profit
YoY Growth in year ended Mar 2024 is -87.68% vs 136.71% in Mar 2023
About Cian Healthcare Ltd 
Cian Healthcare Ltd
Micro Cap
Pharmaceuticals & Drugs
Cian Healthcare Limited was originally incorporated as a Private Limited Company with the name of "Cian Healthcare Private Limited" on January 07, 2003. Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to "Cian Healthcare Limited" pursuant to a fresh Certificate of Incorporation granted by the Registrar of Companies, Pune dated November 30, 2018.
Company Coordinates 
No Company Details Available